Introduction to Pediatric Meningiomas and Recent Research

Pediatric meningiomas represent a rare subset of central nervous system tumors, accounting for approximately 1% to 2% of all intracranial neoplasms in children. Unlike their adult counterparts, which typically follow a more predictable clinical course, pediatric variants often exhibit unique biological behaviors and aggressive phenotypes. Understanding pediatric meningiomas prognostic factors is essential for refining neurosurgical strategies and improving long-term survivorship. A recent comprehensive retrospective analysis of 198 pediatric patients over a ten-year period has provided significant clarity regarding these rare lesions. This study, conducted at a high-volume neurosurgical center, highlights the differences in clinical presentation, anatomical distribution, and pathological grading compared to adult populations. Researchers found that while these tumors are infrequent, they demand specialized management due to their propensity for higher-grade histology and frequent preoperative imaging misdiagnosis. By examining a cohort of this size, clinicians can better identify which children are at the highest risk for recurrence, thereby tailoring postoperative surveillance and adjuvant treatment plans. This information is particularly relevant for pediatric neurosurgeons and oncologists in India, where access to specialized care often necessitates precise risk stratification to optimize resource allocation and patient outcomes.

Demographic and Symptomatic Trends in Children

The demographic profile of pediatric meningiomas deviates significantly from the adult epidemiological landscape. While adult meningiomas show a strong female preponderance, pediatric cohorts often display a slight male predominance or an equal gender distribution. Specifically, in the 198-patient cohort, males comprised approximately 52% of the total cases. Furthermore, the clinical presentation in children is frequently non-specific, leading to substantial diagnostic delays. Notably, nearly 45% of patients in this study were not initially diagnosed with meningioma based on preoperative imaging alone. This high rate of misdiagnosis underscores the radiological challenges associated with pediatric tumors. Consequently, the initial symptoms are often related to focal neurological deficits or signs of increased intracranial pressure. Focal deficits were the most common initial symptoms, appearing in nearly 38% of cases, followed closely by intracranial hypertension in 27%. Interestingly, seizure-related symptoms were observed in approximately 16% of the cohort. Therefore, clinicians must maintain a high index of suspicion when encountering unusual intracranial lesions in children, particularly when symptoms like focal weakness or persistent headaches are present. Understanding these early clinical signals is a vital component of the broader pediatric meningiomas prognostic factors framework, as early detection facilitates more complete surgical resection.

Anatomical Distribution and Radiological Challenges

The anatomical distribution of meningiomas in the pediatric population is distinct, with a higher frequency of tumors occurring in locations that are relatively rare in adults. In this 10-year cohort, the skull base remained the most common site, accounting for approximately 35% of cases. However, intraventricular locations were found in nearly 16% of patients, which is a significantly higher proportion than what is typically observed in adult series. Additionally, parenchymal meningiomas, which lack a direct dural attachment, accounted for nearly 10% of the cases. Such unusual locations frequently contribute to the high rate of radiological misdiagnosis mentioned previously. Because these tumors often appear in deep-seated or intra-axial locations, they may mimic other more common pediatric brain tumors like gliomas or ependymomas. Moreover, the presence of these tumors in the skull base poses significant surgical challenges, as they often involve critical neurovascular structures. Consequently, the radiological evaluation must be meticulous, utilizing advanced MRI sequences to differentiate meningiomas from other pathologies. Accurate anatomical localization is not just a surgical necessity; it also serves as one of the indirect pediatric meningiomas prognostic factors, as tumor location directly influences the feasibility of achieving a gross total resection, which remains a primary determinant of recurrence.

Histopathological Insights and WHO Grading

Histopathological analysis reveals that pediatric meningiomas are often more biologically aggressive than adult variants. In the studied cohort, WHO grade 2 and grade 3 tumors accounted for a striking 43.43% of cases. This high proportion of high-grade tumors suggests a more proliferative nature in childhood meningeal neoplasms. Interestingly, however, the multivariate analysis indicated that high-grade pathology was not a significantly independent predictor of recurrence in this specific pediatric group. This finding contrasts with adult data, where WHO grade is often a dominant prognostic indicator. Furthermore, immunohistochemical markers such as the Ki-67 proliferation index are frequently elevated in these pediatric cases, reflecting rapid cellular turnover. Although high-grade tumors were prevalent, many children achieved favorable long-term survival, provided that surgical resection was extensive. Therefore, the biological behavior of these tumors may be influenced by age-specific factors that are not yet fully captured by standard adult-centric grading systems. Moreover, the association with genetic syndromes, particularly Neurofibromatosis Type 2 (NF2), must always be considered in pediatric cases. While sporadic cases are more common, patients with underlying genetic predispositions often present with multiple tumors and higher recurrence rates, further complicating the histopathological and clinical landscape of pediatric meningiomas prognostic factors.

Key Pediatric Meningiomas Prognostic Factors for Recurrence

Identifying reliable pediatric meningiomas prognostic factors is critical for establishing appropriate follow-up protocols. Through multivariate Cox proportional hazards regression analysis, researchers identified three independent factors that significantly influence the risk of tumor recurrence. First, a younger age at diagnosis—specifically children under 14 years—was associated with a higher risk of recurrence. This suggests that tumors arising in early childhood may possess a more aggressive molecular signature or a different microenvironmental interaction compared to those in older adolescents. Second, the extent of surgical resection remains paramount. Patients who underwent partial resection had significantly higher hazard ratios for recurrence compared to those achieving gross total resection. This reinforces the long-standing surgical principle that achieving a Simpson Grade 1 or 2 resection is the most effective way to prevent future regrowth. Third, a history of prior recurrence was a strong predictor of subsequent failures, indicating a subset of tumors that are inherently resistant to standard surgical intervention. Notably, these findings provide a clear roadmap for risk stratification. Consequently, younger patients or those with residual tumor volume should be subjected to more frequent imaging surveillance and potentially earlier consideration of adjuvant therapies such as radiotherapy or targeted molecular treatments to mitigate the high recurrence risk.

Survival Outcomes and Clinical Management Trends

Despite the high proportion of high-grade tumors and the risk of recurrence, the overall survival (OS) rates for pediatric meningiomas remain encouraging. In this 10-year cohort, the 5-year overall survival rate was over 96%, and the 10-year OS rate was approximately 89%. However, the progression-free survival (PFS) rates were lower, with a 5-year PFS of 83% and a 10-year PFS of 73%. This discrepancy indicates that while recurrence is common, many children can be successfully managed through repeat surgeries or salvage therapies. Therefore, the long-term management of these patients requires a multidisciplinary approach involving neurosurgeons, pediatric oncologists, and radiation therapists. Ultimately, the goal is to balance aggressive tumor control with the preservation of neurodevelopmental function. Furthermore, the high rate of long-term survival underscores the importance of monitoring for late-onset complications, including endocrine dysfunction or cognitive changes following radiotherapy. As molecular diagnostics become more integrated into clinical practice, the identification of specific genetic mutations may soon supplement traditional pediatric meningiomas prognostic factors, allowing for even more personalized treatment strategies. For now, surgical excellence and vigilant monitoring based on identified risk factors remain the cornerstones of care for children with these rare intracranial tumors.

Frequently Asked Questions

How do pediatric meningiomas differ from adult meningiomas?

Pediatric meningiomas are rare and often present with a slight male predominance, unlike the female-heavy adult population. They are more frequently located in unusual sites like the ventricles or brain parenchyma and have a higher incidence of high-grade pathology (WHO grades 2 and 3) compared to adult cases.

What role does the extent of resection play in pediatric cases?

The extent of surgical resection is a critical independent prognostic factor for recurrence in children. Patients who undergo partial resection have a significantly higher risk of tumor regrowth. Consequently, achieving gross total resection (Simpson grade 1 or 2) is the primary goal to ensure better progression-free survival.

Why is preoperative misdiagnosis common in pediatric meningiomas?

Misdiagnosis occurs in nearly 45% of cases because pediatric meningiomas often lack typical adult radiological features, such as clear dural tails. Their frequent occurrence in atypical locations, like the intraventricular or intraparenchymal spaces, causes them to mimic other common childhood brain tumors, leading to diagnostic challenges for radiologists.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Ma J et al. Distinct clinical characteristics and prognostic factors of pediatric meningiomas in a 10-year cohort of 198 patients. Neurosurg Rev. 2026 Jul 13. doi: 10.1007/s10143-026-04395-7. PMID: 42437860.

Dotson D. Prognostic Factors Related to Meningioma Growth: A Meta-Analysis. J Neurol Surg A Cent Eur Neurosurg. 2026; doi:10.1055/a-2846-3421.

Lee SH et al. Ki67 Index Is the Most Powerful Factor for Predicting the Recurrence in Atypical Meningioma: Retrospective Analysis of 99 Patients in Two Institutes. J Korean Neurosurg Soc. 2022;65(4):565-573. doi:10.3340/jkns.2021.0196.

",
"focus_keyword": "Pediatric meningiomas prognostic factors"
}